TCRG Editor 
The latest achievement of our research group is the involvement in the National guidelines by British Echo Society on Contrast echocardiography. Ultrasound contrast agent (UCA) has been well established as a safe, cost-effective, and reliable imaging toolfor detecting heart disease. UCA is an essential component of echocardiography laboratories, it reduces the need for additional downstream … Read more
Here is an interesting insight from the ASIAN-HF Registry on Heart failure and left ventricular ejection fraction in the normal range (HFnEF) being understudied. Click here to read the full article.
Computed tomography coronary angiography (CTCA) offers detailed assessment of the presence of coronary atherosclerosis and helps guide patient management. We investigated influences of early CTCA on the subsequent use of preventative treatment in patients with suspected acute coronary syndrome. Read the full investigation here.
Device-detected atrial high-rate episodes (AHREs) are atrial arrhythmias detected by implanted cardiac devices. AHREs resemble atrial fibrillation but are rare and brief. Whether the occurrence of AHREs in patients without atrial fibrillation (as documented on a conventional electrocardiogram [ECG]) justifies the initiation of anticoagulants is not known. Please take a look at the full article … Read more
Echocardiography is an effective tool for diagnosing cardiovascular disease. However, numerouschallenges affect its accessibility, including skill requirements, workforce shortage, and sonographerstrain. Continue reading the full article by clicking here.
Arrhythmogenic-cardiomyopathy (ACM) is an inherited heart disease with right, left,or biventricular (BVACM) involvement based on EKG, imaging, family history, andgenetic testing. We present a 64-year-old woman with prior myocarditis and diagnosisof BVACM 29 years later. We propose myocarditis as a promoter of gene expression ofplakophilin-2 mutation. Please click here to read the full case report.
Epicardial adipose tissue (EAT) volume is a marker of visceral obesity that can be measured in coronarycomputed tomography angiograms (CCTA). The clinical value of integrating this measurement in routine CCTAinterpretation has not been documented. Please click here to read the full publiation.
We present assessment of chest pain patients by multiparametric dobutamine stress echocardiography to differentiate inducible ischemia with obstructive coronary artery disease and with no obstructive coronary artery disease. In addition to the classical regional wall motion abnormality, we illustrate how coronary flow velocity reserve by Doppler echocardiography assists diagnosing coronary microvascular dysfunction. Please click here … Read more
There is a new release showing the reduced value of CT-FFR in chest pain assessment published as a pre release in JACC-Cardiovascular Imaging. The article can be found here.
Wearable devices could be used to continuously monitor vital signs in patients who are hospitalized, but theyrequire validation. This study aimed to evaluate the clinical validity of the prototype of a semiautomated wearable wrist device (ChroniSense Polso) to measure vital signs and provide National Early Warning Scores (NEWSs). Read the full study by clicking here.